guest ::
| Home > Publications database > In silico/in vitro screening and hit evaluation identified new phenothiazine anti-prion derivatives > print |
| Home > Publications database > In silico/in vitro screening and hit evaluation identified new phenothiazine anti-prion derivatives > print |
| 001 | 884076 | ||
| 005 | 20230217124544.0 | ||
| 024 | 7 | _ | |a 10.1016/j.ejmech.2020.112295 |2 doi |
| 024 | 7 | _ | |a 0009-4374 |2 ISSN |
| 024 | 7 | _ | |a 0223-5234 |2 ISSN |
| 024 | 7 | _ | |a 1768-3254 |2 ISSN |
| 024 | 7 | _ | |a 2128/26976 |2 Handle |
| 024 | 7 | _ | |a 32325366 |2 pmid |
| 024 | 7 | _ | |a WOS:000530224900004 |2 WOS |
| 037 | _ | _ | |a FZJ-2020-03077 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Zaccagnini, Ludovica |0 P:(DE-HGF)0 |b 0 |
| 245 | _ | _ | |a In silico/in vitro screening and hit evaluation identified new phenothiazine anti-prion derivatives |
| 260 | _ | _ | |a Amsterdam [u.a.] |c 2020 |b Elsevier71544 |
| 264 | _ | 1 | |3 print |2 Crossref |b Elsevier BV |c 2020-06-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1611417094_30479 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Prion diseases or transmissible spongiform encephalopathies (TSEs) are a group of rare neurodegenerative disorders. TSEs are characterized by the accumulation of prions (PrPSc) that represent pathological isoforms of the physiological cellular prion protein PrPC. Although the conversion of PrPC to PrPSc is still not completely understood, blocking this process may lead to develop new therapies. Here, we have generated a pharmacophore model, based on anti-prion molecules reported in literature to be effective in phenotypic assay. The model was used to conduct a virtual screen of commercial compound databases that selected a small library of ten compounds. These molecules were then screened in mouse neuroblastoma cell line chronically infected with prions (ScN2a) after excluding neurotoxicity. 1 has been identified as the therapeutic hit on the basis of the following evidence: chronic treatments of ScN2a cells using 1 eliminate PrPSc loaded in both Western blotting analysis and Real-Time Quaking-Induced Conversion (RT-QuIC) assay. We also proposed the mechanism of action of 1 by which it has the ability to bind PrPC and consequentially blocks prion conversion. Herein we describe the results of these efforts. |
| 536 | _ | _ | |a 574 - Theory, modelling and simulation (POF3-574) |0 G:(DE-HGF)POF3-574 |c POF3-574 |f POF III |x 0 |
| 536 | _ | _ | |a 511 - Computational Science and Mathematical Methods (POF3-511) |0 G:(DE-HGF)POF3-511 |c POF3-511 |f POF III |x 1 |
| 542 | _ | _ | |i 2020-06-01 |2 Crossref |u https://www.elsevier.com/tdm/userlicense/1.0/ |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Rossetti, Giulia |0 P:(DE-Juel1)145921 |b 1 |
| 700 | 1 | _ | |a Tran, Thanh Hoa |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Salzano, Giulia |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Gandini, Annachiara |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Colini Baldeschi, Arianna |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Bolognesi, Maria Laura |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Carloni, Paolo |0 P:(DE-Juel1)145614 |b 7 |
| 700 | 1 | _ | |a Legname, Giuseppe |0 P:(DE-HGF)0 |b 8 |e Corresponding author |
| 773 | 1 | 8 | |a 10.1016/j.ejmech.2020.112295 |b Elsevier BV |d 2020-06-01 |p 112295 |3 journal-article |2 Crossref |t European Journal of Medicinal Chemistry |v 196 |y 2020 |x 0223-5234 |
| 773 | _ | _ | |a 10.1016/j.ejmech.2020.112295 |g Vol. 196, p. 112295 - |0 PERI:(DE-600)2005170-0 |p 112295 |t European journal of medicinal chemistry |v 196 |y 2020 |x 0223-5234 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/884076/files/Journal%20Pre-Proof.pdf |y Published on 2020-04-08. Available in OpenAccess from 2022-04-08. |
| 909 | C | O | |o oai:juser.fz-juelich.de:884076 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 1 |6 P:(DE-Juel1)145921 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 7 |6 P:(DE-Juel1)145614 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-574 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-500 |4 G:(DE-HGF)POF |v Theory, modelling and simulation |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Supercomputing & Big Data |1 G:(DE-HGF)POF3-510 |0 G:(DE-HGF)POF3-511 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-500 |4 G:(DE-HGF)POF |v Computational Science and Mathematical Methods |x 1 |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0 |0 LIC:(DE-HGF)CCBYNCND4 |2 HGFVOC |
| 915 | _ | _ | |a Embargoed OpenAccess |0 StatID:(DE-HGF)0530 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J MED CHEM : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)IAS-5-20120330 |k IAS-5 |l Computational Biomedicine |x 0 |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-9-20140121 |k INM-9 |l Computational Biomedicine |x 1 |
| 920 | 1 | _ | |0 I:(DE-Juel1)JSC-20090406 |k JSC |l Jülich Supercomputing Center |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)IAS-5-20120330 |
| 980 | _ | _ | |a I:(DE-Juel1)INM-9-20140121 |
| 980 | _ | _ | |a I:(DE-Juel1)JSC-20090406 |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |a 10.1146/annurev-biochem-061516-044518 |9 -- missing cx lookup -- |1 Hartl |p 21 - |2 Crossref |t Annu. Rev. Biochem. |v 86 |y 2017 |
| 999 | C | 5 | |a 10.1016/S0197-4580(00)00160-3 |9 -- missing cx lookup -- |1 Walker |p 559 - |2 Crossref |t Neurobiol. Aging |v 21 |y 2000 |
| 999 | C | 5 | |a 10.1126/science.1222951 |9 -- missing cx lookup -- |1 Prusiner |p 1511 - |2 Crossref |t Science |v 336 |y 2012 |
| 999 | C | 5 | |a 10.1517/17460441.2015.1016498 |9 -- missing cx lookup -- |1 Bolognesi |p 389 - |2 Crossref |t Expet Opin. Drug Discov. |v 10 |y 2015 |
| 999 | C | 5 | |a 10.1186/1471-2202-15-69 |9 -- missing cx lookup -- |1 Aulić |p 69 - |2 Crossref |t BMC Neurosci. |v 15 |y 2014 |
| 999 | C | 5 | |a 10.1038/ncb1901 |9 -- missing cx lookup -- |1 Clavaguera |p 909 - |2 Crossref |t Nat. Cell Biol. |v 11 |y 2009 |
| 999 | C | 5 | |a 10.1016/j.neuron.2012.02.006 |9 -- missing cx lookup -- |1 Soto |p 621 - |2 Crossref |t Neuron |v 73 |y 2012 |
| 999 | C | 5 | |a 10.1186/s40478-015-0198-y |1 Ulusoy |9 -- missing cx lookup -- |2 Crossref |t Acta Neuropathol. Commun. |v 3 |y 2015 |
| 999 | C | 5 | |a 10.1016/bs.pmbts.2017.06.011 |p 319 - |1 Ritchie |y 2017 |2 Crossref |9 -- missing cx lookup -- |
| 999 | C | 5 | |a 10.1146/annurev-micro-092412-155735 |9 -- missing cx lookup -- |1 Kraus |p 543 - |2 Crossref |t Annu. Rev. Microbiol. |v 67 |y 2013 |
| 999 | C | 5 | |a 10.1073/pnas.95.23.13363 |9 -- missing cx lookup -- |1 Prusiner |p 13363 - |2 Crossref |t Proc. Natl. Acad. Sci. U. S. A. |v 95 |y 1998 |
| 999 | C | 5 | |a 10.1006/jmbi.1994.0030 |9 -- missing cx lookup -- |1 Schätzl |p 362 - |2 Crossref |t J. Mol. Biol. |v 245 |y 1995 |
| 999 | C | 5 | |a 10.1093/bmb/66.1.21 |9 -- missing cx lookup -- |1 Riesner |p 21 - |2 Crossref |t Br. Med. Bull. |v 66 |y 2003 |
| 999 | C | 5 | |a 10.1371/journal.pone.0182589 |1 Stincardini |9 -- missing cx lookup -- |2 Crossref |t PLoS One |v 12 |y 2017 |
| 999 | C | 5 | |a 10.1016/j.bbapap.2012.03.011 |9 -- missing cx lookup -- |1 Dee |p 826 - |2 Crossref |t Biochim. Biophys. Acta BBA - Proteins Proteomics |v 1824 |y 2012 |
| 999 | C | 5 | |1 Pagadala |y 2015 |2 Crossref |o Pagadala 2015 |
| 999 | C | 5 | |1 Furlow |y 1982 |2 Crossref |o Furlow 1982 |
| 999 | C | 5 | |a 10.1212/WNL.0b013e3182a9f3b4 |9 -- missing cx lookup -- |1 Geschwind |p 2015 - |2 Crossref |t Neurology |v 81 |y 2013 |
| 999 | C | 5 | |a 10.1016/S1474-4422(09)70049-3 |9 -- missing cx lookup -- |1 Collinge |p 334 - |2 Crossref |t Lancet Neurol. |v 8 |y 2009 |
| 999 | C | 5 | |a 10.1093/infdis/165.4.784 |9 -- missing cx lookup -- |1 Masullo |p 784 - |2 Crossref |t J. Infect. Dis. |v 165 |y 1992 |
| 999 | C | 5 | |a 10.1016/j.surneu.2005.03.035 |9 -- missing cx lookup -- |1 Martínez-Lage |p 542 - |2 Crossref |t Surg. Neurol. |v 64 |y 2005 |
| 999 | C | 5 | |a 10.1016/j.jinf.2004.07.015 |9 -- missing cx lookup -- |1 Todd |p 394 - |2 Crossref |t J. Infect. |v 50 |y 2005 |
| 999 | C | 5 | |a 10.1111/j.1468-1331.2008.02108.x |9 -- missing cx lookup -- |1 Bone |p 458 - |2 Crossref |t Eur. J. Neurol. |v 15 |y 2008 |
| 999 | C | 5 | |a 10.1016/S1474-4422(13)70307-7 |9 -- missing cx lookup -- |1 Haïk |p 150 - |2 Crossref |t Lancet Neurol. |v 13 |y 2014 |
| 999 | C | 5 | |a 10.1080/19336896.2015.1027857 |9 -- missing cx lookup -- |1 Forloni |p 75 - |2 Crossref |t Prion |v 9 |y 2015 |
| 999 | C | 5 | |a 10.1212/01.WNL.0000113764.35026.EF |9 -- missing cx lookup -- |1 Otto |p 714 - |2 Crossref |t Neurology |v 62 |y 2004 |
| 999 | C | 5 | |a 10.1021/jm101250y |9 -- missing cx lookup -- |1 Gallardo-Godoy |p 1010 - |2 Crossref |t J. Med. Chem. |v 54 |y 2011 |
| 999 | C | 5 | |a 10.1021/jm050610f |9 -- missing cx lookup -- |1 Reddy |p 607 - |2 Crossref |t J. Med. Chem. |v 49 |y 2006 |
| 999 | C | 5 | |a 10.4155/fmc.14.56 |9 -- missing cx lookup -- |1 Bongarzone |p 1017 - |2 Crossref |t Future Med. Chem. |v 6 |y 2014 |
| 999 | C | 5 | |a 10.1016/j.ejmech.2016.10.064 |9 -- missing cx lookup -- |1 Zaccagnini |p 859 - |2 Crossref |t Eur. J. Med. Chem. |v 127 |y 2017 |
| 999 | C | 5 | |a 10.1016/bs.pmbts.2017.06.013 |p 433 - |1 Gandini |y 2017 |2 Crossref |9 -- missing cx lookup -- |
| 999 | C | 5 | |a 10.1002/jcc.23361 |9 -- missing cx lookup -- |1 Gramatica |p 2121 - |2 Crossref |t J. Comput. Chem. |v 34 |y 2013 |
| 999 | C | 5 | |a 10.1002/jps.20913 |9 -- missing cx lookup -- |1 Zhou |p 3052 - |2 Crossref |t J. Pharmacol. Sci. |v 96 |y 2007 |
| 999 | C | 5 | |1 Lipinski |y 2001 |2 Crossref |o Lipinski 2001 |
| 999 | C | 5 | |a 10.1002/jcc.21707 |9 -- missing cx lookup -- |1 Yap |p 1466 - |2 Crossref |t J. Comput. Chem. |v 32 |y 2011 |
| 999 | C | 5 | |a 10.1039/C5RA10729F |9 -- missing cx lookup -- |1 Pirhadi |p 104635 - |2 Crossref |t RSC Adv. |v 5 |y 2015 |
| 999 | C | 5 | |y 2017 |2 Crossref |o 2017 |
| 999 | C | 5 | |y 2010 |2 Crossref |o 2010 |
| 999 | C | 5 | |a 10.1074/jbc.M111.234393 |9 -- missing cx lookup -- |1 Poncet-Montange |p 27718 - |2 Crossref |t J. Biol. Chem. |v 286 |y 2011 |
| 999 | C | 5 | |a 10.1016/j.tetlet.2008.01.128 |9 -- missing cx lookup -- |1 Gemma |p 2074 - |2 Crossref |t Tetrahedron Lett. |v 49 |y 2008 |
| 999 | C | 5 | |a 10.1128/JVI.01563-07 |9 -- missing cx lookup -- |1 Kawasaki |p 12889 - |2 Crossref |t J. Virol. |v 81 |y 2007 |
| 999 | C | 5 | |a 10.1016/0923-2516(96)89651-8 |9 -- missing cx lookup -- |1 Adjou |p 213 - |2 Crossref |t Res. Virol. |v 147 |y 1996 |
| 999 | C | 5 | |a 10.1016/j.neulet.2005.06.053 |9 -- missing cx lookup -- |1 Kocisko |p 106 - |2 Crossref |t Neurosci. Lett. |v 388 |y 2005 |
| 999 | C | 5 | |a 10.2174/15680266113136660168 |9 -- missing cx lookup -- |1 Miller-Vedam |p 2397 - |2 Crossref |t Curr. Top. Med. Chem. |v 13 |y 2013 |
| 999 | C | 5 | |a 10.1016/j.str.2013.11.009 |9 -- missing cx lookup -- |1 Baral |p 291 - |2 Crossref |t Structure |v 22 |y 2014 |
| 999 | C | 5 | |a 10.1155/2017/5413936 |1 Kang |9 -- missing cx lookup -- |2 Crossref |t BioMed Res. Int. |v 2017 |y 2017 |
| 999 | C | 5 | |a 10.1128/JVI.02145-09 |9 -- missing cx lookup -- |1 Ghaemmaghami |p 3408 - |2 Crossref |t J. Virol. |v 84 |y 2010 |
| 999 | C | 5 | |a 10.1002/cmdc.201000133 |9 -- missing cx lookup -- |1 Bolognesi |p 1324 - |2 Crossref |t ChemMedChem |v 5 |y 2010 |
| 999 | C | 5 | |a 10.1126/scitranslmed.aab1923 |1 Herrmann |9 -- missing cx lookup -- |2 Crossref |t Sci. Transl. Med. |v 7 |y 2015 |
| 999 | C | 5 | |a 10.1371/journal.pone.0170266 |1 Hyeon |9 -- missing cx lookup -- |2 Crossref |t PLoS One |v 12 |y 2017 |
| 999 | C | 5 | |a 10.1371/journal.ppat.1000673 |1 Ghaemmaghami |9 -- missing cx lookup -- |2 Crossref |t PLoS Pathog. |v 5 |y 2009 |
| 999 | C | 5 | |a 10.1021/cn200100h |9 -- missing cx lookup -- |1 Ghose |p 50 - |2 Crossref |t ACS Chem. Neurosci. |v 3 |y 2012 |
| 999 | C | 5 | |a 10.1111/j.1600-0404.2009.01272.x |9 -- missing cx lookup -- |1 Terada |p 127 - |2 Crossref |t Acta Neurol. Scand. |v 121 |y 2010 |
| 999 | C | 5 | |a 10.1371/journal.pone.0001888 |1 De Luigi |9 -- missing cx lookup -- |2 Crossref |t PLoS One |v 3 |y 2008 |
| 999 | C | 5 | |a 10.1073/pnas.161274798 |9 -- missing cx lookup -- |1 Korth |p 9836 - |2 Crossref |t Proc. Natl. Acad. Sci. U. S. A. |v 98 |y 2001 |
| 999 | C | 5 | |a 10.1517/17460441.2011.550914 |9 -- missing cx lookup -- |1 Bongarzone |p 251 - |2 Crossref |t Expet Opin. Drug Discov. |v 6 |y 2011 |
| 999 | C | 5 | |a 10.1021/acschemneuro.8b00242 |9 -- missing cx lookup -- |1 Uliassi |p 279 - |2 Crossref |t ACS Chem. Neurosci. |v 10 |y 2019 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|